MIST - Milestone Pharmaceuticals GAAP EPS of -$0.39 misses by $0.03 August, 10 2022 04:59 PM Milestone Pharmaceuticals Inc. Milestone Pharmaceuticals press release ( NASDAQ: MIST ): Q2 GAAP EPS of -$0.39 misses by $0.03 . cash, cash equivalents, and short-term investments of $86.2 million For further details see: Milestone Pharmaceuticals GAAP EPS of -$0.39 misses by $0.03